Internal Medicine, Cardiovascular Disease · Jacksonville, FL
NPI
1770556243
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4500 San Pablo Rd S
Jacksonville, FL, 32224
Phone (904) 953-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
865 services
Medicare patients, 2024
269
Average age 73
Drug cost, 2024
$3.2M
1,108 prescriptions
Company payments, 2025
$118K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew W Martinez was code 93306 (echocardiography (tte/tee)), 247 times for 146 patients. In total Matthew W Martinez billed 865 services in 25 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Office | 247 | 146 | $51.70 | $13K |
| 99215 Office E&M - Established | Office | 243 | 181 | $147.77 | $36K |
| 93000 Electrocardiogram | Office | 157 | 145 | $11.88 | $1,865 |
| 99214 Office E&M - Established | Office | 69 | 59 | $100.36 | $6,925 |
| 75561 MRI/MRA - Other | Facility | 35 | 35 | $96.19 | $3,367 |
| 99205 Office E&M - New | Office | 29 | 29 | $175.67 | $5,094 |
| 93242 Electrocardiogram | Office | 12 | 12 | $10.97 | $132 |
| 93244 Electrocardiogram | Office | 11 | 11 | $19.29 | $212 |
By year: 2022 $36K for 493 services; 2023 $47K for 666 services; 2024 $70K for 865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew W Martinez prescribed most often to Medicare patients was Camzyos (Mavacamten), with 354 prescriptions and refills. In total Matthew W Martinez wrote 1,108 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Camzyos Mavacamten | 354 | 354 | 47 | $2.9M |
| Metoprolol Succinate Generic | 106 | 304 | 45 | $1,442 |
| Verapamil Er Verapamil Hcl | 73 | 220 | 27 | $2,578 |
| Amoxicillin Generic | 65 | 79 | 37 | $60.88 |
| Jardiance Empagliflozin | 58 | 116 | 17 | $64K |
| Eliquis Apixaban | 55 | 130 | 18 | $74K |
| Entresto Sacubitril/Valsartan | 45 | 88 | 13 | $56K |
| Farxiga Dapagliflozin Propanediol | 41 | 85 | Under 11 | $46K |
| Losartan Potassium Generic | 40 | 106 | 13 | $555 |
| Spironolactone Generic | 31 | 93 | 15 | $457 |
| Atorvastatin Calcium Generic | 28 | 78 | 12 | $241 |
| Metoprolol Tartrate Generic | 17 | 47 | Under 11 | $134 |
| Valsartan Generic | 13 | 29 | Under 11 | $640 |
| Rosuvastatin Calcium Generic | 12 | 36 | Under 11 | $323 |
Brand drugs: 587 claims; generic drugs: 521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew W Martinez $118K ($118K in general payments such as food, travel and fees) from 13 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $116K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 94 | $116K |
| Genzyme Corporation SNY | 7 | $1,074 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $126 |
| Pfizer Inc. PFE | 7 | $113 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $60.61 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $59.6 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $41.57 |
| Heartflow, Inc. HTFL | 2 | $39.52 |
| BridgeBio Pharma, Inc. BBIO | 2 | $34.2 |
| Amgen Inc. AMGN | 2 | $31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.